G. Davis - Concepedia

Author

G. Davis

University of Florida

Also Known As

G Davis, G. Davis, G.L. Davis, Gary L. Davis

Publications

657

Citations

H-Index

Concepts

All Affiliations

University of Florida

About

G. Davis is an author at University of Florida specializing in medicine, hepatology, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	500
2	Hepatology	4	4	451
3	Management	1	1	19
4	Public Health	1	1	30
5	Obstetrics	1	1	30

G. Davis

Publications

649

Citations

H-Index

Page 1

	Year	Citations
Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B Jay H. Lefkowitch, Eugene R. Schiff, G. Davis, Gastroenterology Hepatitis DHepatologyHepatitis CViral HepatitisMedicine	1993	374
Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C David R. Nelson, Constantine G. Marousis, Tomoyoshi Ohno, Hepatology	1998	135
A Psychometric Normative Database for Pre-Liver Transplantation Evaluations Randi Streisand, James R. Rodrigue, Samuel F. Sears, Psychosomatics Psychometric Normative DatabaseHepatologySolid Organ TransplantationOutcomes ResearchLiver Transplantation	1999	49
A Double-Blind, Placebo-Controlled Trial of the Effect of Chronically Administered Oral Acyclovir on Sperm Production in Men With Frequently Recurrent Genital Herpes Jacinta Douglas, G. Davis, Michael Remington, The Journal of Infectious Diseases Reproductive SciencesFertilityReproductive HealthGynecologyPlacebo-controlled Trial	1988	30
Modeling therapeutic benefit in the midst of uncertainty William G. Bennett, Stephen G. Pauker, G. Davis, Digestive Diseases and Sciences Therapeutic BenefitTherapeutic ModelManagementRiskbenefit RatioDecision Science	1996	19
113 A phase 2 dose-escalation study of albuferon combined with ribavirin in non-responders to prior interferon-based therapy for chronic hepatitis C infection V. Rustgi, D. Nelson, Vijayan Balan, Journal of Hepatology Dose-escalation StudyA Phase 2HepatologyViral HepatitisAntiviral Drug Development	2006	17
1406 ALISPORIVIR (ALV) PLUS PEG-INTERFERON/RIBAVIRIN (PR) IN HCV G1 TREATMENT-EXPERIENCED PATIENTS ACHIEVES PRIMARY ENDPOINT WITH SUPERIOR EFFICACY AT TREATMENT WEEK 12 COMPARED TO RETREATMENT WITH PR Antonio Alberti, Wan‐Long Chuang, Robert Flisiak, Journal of Hepatology	2012	14
Durability of viral response to interferon ribavirin combination in patients with chronic hepatitis C Thierry Poynard, John G. McHutchison, G. Davis, Journal of Hepatology Viral PersistenceHepatologyHepatitis CViral HepatitisAntiviral Therapy	2001	11

Page 1